The Board of Directors of Ortivus AB has decided to appoint Reidar Gårdebäck as new Managing Director of Ortivus AB effective from August 5, 2019. At the same time, Lars Höst, who since the summer of 2018 serves as acting CEO, return to his role as CFO for Ortivus AB.
Reidar Gårdebäck has more than 25 years of experience from marketing and sales in the healthcare market. He has worked as CEO of several international MedTech companies and has been active in introducing new technical solutions to the market. During the years 2015-2018, Reidar Gårdebäck was program director for the Vinnova-funded national strategic innovation program Medtech4Health, which aims to streamline health and healthcare services and strengthen the Swedish MedTech industry. He most recently comes from the consultancy company Spark Group, which since January 2019 has reinforced Ortivus’ organization in the areas of sales, product management, and marketing.
“I am pleased that we can present Reidar Gårdebäck as new CEO. He adds new skills and experiences when we now strive to position Ortivus to fully utilize the market potential and create profitable growth. Since Reidar Gårdebäck has been active in the company as a consultant for more than six months, he already has a good insight, both in terms of strengths and weaknesses. Lars Höst has made a strong contribution as acting CEO, and now we create opportunities for him as CFO to focus on developing and operating Ortivus financial issues. I look forward to co-operating with Reidar and the whole team at Ortivus”, says Anders Paulsson, Chairman of Ortivus since May 2019.
”Demand from the market has increased significantly in the past year. Ortivus also has a strong and good product portfolio, combined with a broad customer base that gives us good references when we now increase the pace of our marketing work. All in all, this creates a good potential for growth, with a focus on increased profitability in the coming years”, says Reidar Gårdebäck.
For further information, please contact
Anders Paulsson, Chairman of the Board, Ortivus AB
Telephone +46 (0) 8 446 45 00
Ortivus was founded in 1985, based on clinical experience in cardiology, and has its headquarters in Danderyd, outside Stockholm. The company has had a presence in the UK through its own subsidiary since 1998. Through its proprietary, module-based MobiMed technology platform, Ortivus offers its customers real-time monitoring of patients in prehospital care and MobiMed ePR – a decision support system that can be integrated in real time with patient management systems in the healthcare setting and with external patient systems. Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
Read more about Ortivus at www.ortivus.com
Ortivus publishes this information according to the EU Market Abuse Regulation (MAR). The information was submitted for publication at. 14:00 on June 13, 2019.